Osteoporosis Management- Pharmacy Technician


  Credits  1.5

This product is currently out of stock and unavailable.

Osteoporosis is the most common bone disease and threatens an estimated 44 million Americans. Of these, 10 million suffer from osteoporosis and 34 million are at risk for fracture due to low bone mass (osteopenia). Half of all postmenopausal women and 1 in 5 men over the age of 50 will have an osteoporosis-related fracture in their lifetimes. The most common sites for these fractures are the spine, hip, and wrist. Hip fractures are particularly devastating, with a 10-20% risk of death in the year following the fracture. Osteoporosis is more prevalent in women than men; however, the impact of osteoporosis among older men is commonly underestimated. Osteoporosis affects more men than prostate cancer (the most common cancer in men) and is more likely to result in disability or death. This issue focuses on the drug and nondrug therapies recommended for osteoporosis prevention and treatment. The management of osteoporosis resulting from long-term glucocorticoid therapy is included. The potential benefits, side effects, drug interactions, and optimal use of bisphosphonates, raloxifene, calcitonin, teriparatide, and estrogen replacement therapy are reviewed with key information presented in easy-to-read tables. Risk factors for osteoporosis and the criteria that are used to select candidates for bone mineral density (BMD) testing and drug therapy are also discussed.


Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Tech Drug Therapy

Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Course Accreditation

  • Activity Type:
  • CE Broker
  • Universal Activity Number:
    Pharmacy Technician : 428-0000-09-003-H01-T
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.